Evolutionary Genomics Inc
OTC:FNAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evolutionary Genomics Inc
OTC:FNAM
|
US |
|
D
|
Development Investment Construction Hoi An JSC
VN:DIH
|
VN |
|
M
|
Mgame Corp
KOSDAQ:058630
|
KR |
|
First Resources Ltd
F:5F1
|
SG |
|
Kesselrun Resources Ltd
XTSX:KES
|
CA |
|
SharpLink Gaming Inc
F:7710
|
US |
|
T
|
TMBThanachart Bank PCL
SET:TTB
|
TH |
|
S
|
Solv Energy Inc
NASDAQ:MWH
|
US |
|
Yamaguchi Financial Group Inc
TSE:8418
|
JP |
|
ImmuCell Corp
NASDAQ:ICCC
|
US |
|
Genex Power Ltd
ASX:GNX
|
AU |
Bankruptcy Probability
Evolutionary Genomics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Evolutionary Genomics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Evolutionary Genomics Inc
OTC:FNAM
|
1.3k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
485.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
31.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
29.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
26.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
25.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Evolutionary Genomics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Evolutionary Genomics Inc has total debt of 3.7m USD. This includes both short-term (0 USD) and long-term (3.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
